Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions
Overview
The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.
Study Type
- Study Type: Observational
- Study Design
Clinical Trial Outcome Measures
Primary Measures
- continuous collection of donated study subject samples
- Time Frame: unknown, continuous sample collection
Participating in This Clinical Trial
Inclusion Criteria
- Willing and able to provide written, signed informed consent – Willing and able to comply with all study procedures Exclusion Criteria:
- Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study – Concurrent disease or condition that would interfere with study participation or safety.
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- BioMarin Pharmaceutical
- Provider of Information About this Clinical Study
- Sponsor
- Overall Contact(s)
- Evelyn Wang, 415-506-6818, EWang@bmrn.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.